KIA
ABBV icon

KLR Investment Advisors’s AbbVie ABBV Stock Holding History

KLR Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$726K Buy
4,283
+78
+2% +$13.4K 0.52% 44
2023
Q4 		$652K Sell
4,205
-460
-10% -$67.1K 0.47% 50
2023
Q3 		$743K Buy
4,665
+468
+11% +$68.7K 0.68% 38
2023
Q2 		$565K Sell
4,197
-684
-14% -$100K 0.47% 56
2023
Q1 		$778K Sell
4,881
-924
-16% -$141K 0.68% 38
2022
Q4 		$938K Buy
+5,805
New +$890K 0.77% 26

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

KLR Investment Advisors's ABBV Position: Q1 2024 in Review

KLR Investment Advisors increased its AbbVie (ABBV) stake by 1.9% in Q1 2024, buying an estimated $13.4K and bringing the position to 4,283 shares worth $726K. The position accounts for 0.52% of the portfolio, ranked #44.

KLR Investment Advisors first reported a position in ABBV in Q4 2022 and has held it in 6 quarters since. The position peaked at $938K in Q4 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • KLR Investment Advisors held 4,283 shares of AbbVie worth $726K as of Q1 2024.
  • KLR Investment Advisors bought 78 AbbVie shares in Q1 2024, an estimated $13.4K.
  • AbbVie made up 0.52% of KLR Investment Advisors's portfolio in Q1 2024, its #44 holding.
  • KLR Investment Advisors first reported a position in AbbVie in Q4 2022 and has held it in 6 quarters since.
  • KLR Investment Advisors's AbbVie position peaked at $938K in Q4 2022.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on KLR Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.